Worsening UK Pharma Sector Close To ‘Tipping Point,’ Warns GSK Chief
UK Falling Behind On Trials, Medicines Uptake And Regulation
Dame Emma Walmsley has delivered a broadside to the UK government, urging it to reverse a raised revenues ‘clawback’ for pharma companies and boost new medicines uptake in order to maintain the UK’s competitiveness in life sciences.
